Mohadjer Ashley, Brown Garrett, Shah Syed R, Nallapati Charishma, Waheed Nida, Bavry Anthony A, Park Ki
Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA.
Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, USA.
Cardiol Ther. 2020 Dec;9(2):257-273. doi: 10.1007/s40119-020-00176-5. Epub 2020 May 21.
In the current state of interventional cardiology, the ability to offer advanced therapies to patients who historically were not surgical candidates has grown exponentially in the last few decades. As therapies have expanded in complex coronary and structural interventions, the nuances of treating certain populations have emerged. In particular, the role of sex-based anatomic and outcome differences has been increasingly recognized. As guidelines for cardiovascular prevention and treatment for certain conditions may vary by sex, therapeutic interventions in the structural and percutaneous coronary areas may also vary. In this review, we aim to discuss these differences, the current literature available on these topics, and areas of focus for the future.
在当前的介入心脏病学领域，在过去几十年里，为那些历来不适合接受手术的患者提供先进治疗的能力呈指数级增长。随着复杂冠状动脉和结构性干预治疗方法的不断扩展，治疗特定人群的细微差别也逐渐显现出来。特别是，基于性别的解剖学和结果差异的作用已得到越来越多的认可。由于某些疾病的心血管预防和治疗指南可能因性别而异，结构性和经皮冠状动脉领域的治疗干预也可能有所不同。在本综述中，我们旨在讨论这些差异、关于这些主题的现有文献以及未来的重点关注领域。
